| Market Cap | ₹61,442Cr |
| ROE | 37.62% |
| P/E Ratio(TTM) | 40.72 |
| EPS(TTM) | 710.09 |
| P/B Ratio | 15.32 |
| Dividend Yield | 1.64% |
| Industry P/E | 39.95 |
| Book Value | 1887.49 |
| Debt to Equity | 0.05 |
| Face Value | 10 |
| Parent Organisation | Abbott India Limited |
| Managing Director | Mr. Vivek Kamath |
| Founded | 1944 |
| NSE Symbol | ABBOTINDIA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 43.92 | ||
| Pfizer | NA (0.00%) | 27.02 | ||
| Astrazeneca Pharma India | NA (0.00%) | 113.38 | ||
| Sanofi Consumer Healthcare India | NA (0.00%) | 48.48 |